| J0897 | Injection, denosumab, 1 mg | 6,960 | $20 | $125.3K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 500 | $130 | $66.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 630 | $70 | $44.9K |
| J3145 | Injection, testosterone undecanoate, 1 mg | 32,250 | $1 | $32.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 320 | $40 | $13.9K |
| J9155 | Injection, degarelix, 1 mg | 3,200 | $1 | $9.6K |
| 96402 | In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug. | 190 | $20 | $3.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 30 | $90 | $2.3K |
| 99221 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a straightforward or low level of medical… | 40 | $50 | $2K |
| 99231 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a straightforward or low level of medical… | 60 | $30 | $1.7K |